<ul>S</ul>ystemic hydrocortisone <ul>to </ul><ul>p</ul>revent <ul>b</ul>roncho<ul>p</ul>ulmonary <ul>d</ul>ysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial

<ul>S</ul>ystemic hydrocortisone <ul>to </ul><ul>p</ul>revent <ul>b</ul>roncho<ul>p</ul>ulmonary <ul>d</ul>ysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial

<p>Abstract</p> <p>Background</p> <p>Randomized controlled trials have shown that treatment of chronically ventilated preterm infants after the first week of life with dexamethasone reduces the incidence of the combined outcome death or bronchopulmonary dysplasia (BPD)....

Full description

Bibliographic Details
Main Authors: Onland Wes, Offringa Martin, Cools Filip, De Jaegere Anne P, Rademaker Karin, Blom Henry, Cavatorta Eric, Debeer Anne, Dijk Peter H, van Heijst Arno F, Kramer Boris W, Kroon Andre A, Mohns Thilo, van Straaten Henrica L, te Pas Arjan B, Theyskens Claire, van Weissenbruch Mirjam M, van Kaam Anton H
Format: Article
Language:English
Published: BMC 2011-11-01
Series:BMC Pediatrics
Online Access:http://www.biomedcentral.com/1471-2431/11/102

Internet

http://www.biomedcentral.com/1471-2431/11/102

Similar Items